Literature DB >> 2951341

Comparative study of bepridil and nicardipine action on respiration and calcium transport in mitochondria.

C Tari, N Fournier, G Ducet, A Crevat, E Albengres, S Urien, J P Tillement.   

Abstract

Effects of the calcium antagonists bepridil and nicardipine on mitochondrial functions were studied and their effects on respiratory control and calcium fluxes were compared. Results show that bepridil and nicardipine similarly increase Ca2+ intracellular movements, but that intramitochondrial Ca2+ storage is increased by bepridil whereas it is decreased by nicardipine. The in vivo significance of these findings remain to be determined. The effect of bepridil might be related to an enhancement of mitochondrial ATPase activity whereas nicardipine would act on mitochondria by a different mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951341

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  6 in total

1.  Binding of bepridil to isolated rat heart mitochondria.

Authors:  J M Schneider; A Younes
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

2.  Preventive effect of nicardipine on hyperplastic changes in venous bypass grafts.

Authors:  O Gökçe; C Gökçe; S Günel; A Ozden; K Hüseyinoğlu; O Uçar; Y Güngen
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

Review 3.  Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.

Authors:  L M Hollingshead; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 4.  Bepridil: a pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia.

Authors:  R Massingham; P A Van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

5.  Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.

Authors:  C H Thompson; V M Macaulay; K J O'Byrne; G J Kemp; S M Wilner; D C Talbot; A L Harris; G K Radda
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

6.  Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers.

Authors:  Charles E Mordaunt; Dorothy A Kieffer; Noreene M Shibata; Anna Członkowska; Tomasz Litwin; Karl-Heinz Weiss; Yihui Zhu; Christopher L Bowlus; Souvik Sarkar; Stewart Cooper; Yu-Jui Yvonne Wan; Mohamed R Ali; Janine M LaSalle; Valentina Medici
Journal:  Epigenetics Chromatin       Date:  2019-02-01       Impact factor: 4.954

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.